• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

20例复发性川崎病患儿的临床特征

[Clinical features of recurrent Kawasaki disease in 20 children].

作者信息

Zou Li-Xia, Gong Fang-Qi

机构信息

Department of Internal Medicine, Children's Hospital Affiliated to School of Medicine of Zhejiang University, Hangzhou 310003, China.

出版信息

Zhongguo Dang Dai Er Ke Za Zhi. 2008 Oct;10(5):617-9.

PMID:18947484
Abstract

OBJECTIVE

To investigate the clinical features of recurrent Kawasaki disease (KD) and the relationship of recurrent KD with coronary artery lesions.

METHODS

The medical data of 20 children with recurrent KD who were admitted to the Children's Hospital from January 1998 to May 2007 were retrospectively studied. Their clinical features were compared with those of children with initial KD.

RESULTS

The incidence of recurrent KD was 1.34% (20/1489). KD relapsed 2 months to 4.6 years (average: 1.2 years) after the first episode in the 20 children. Compared with the initial KD group, the clinical symptoms in the recurrent KD group were incomplete, complicated and less severe. The period of fever, platelet count, C-reactive protein and ESR were remarkably reduced in the recurrent KD group, but the incidence of coronary artery lesions increased significantly compared with the initial KD group (40% vs 25%; P<0.05).

CONCLUSIONS

The clinical symptoms of recurrent KD were incomplete in children. Recurrent KD was associated with an increased incidence of coronary artery lesions.

摘要

目的

探讨复发性川崎病(KD)的临床特征以及复发性KD与冠状动脉病变的关系。

方法

回顾性研究1998年1月至2007年5月在儿童医院收治的20例复发性KD患儿的医疗资料。将其临床特征与初发性KD患儿的临床特征进行比较。

结果

复发性KD的发生率为1.34%(20/1489)。20例患儿在首次发病后2个月至4.6年(平均1.2年)复发KD。与初发性KD组相比,复发性KD组的临床症状不典型、复杂且较轻。复发性KD组的发热时间、血小板计数、C反应蛋白和血沉显著降低,但与初发性KD组相比,冠状动脉病变的发生率显著增加(40%对25%;P<0.05)。

结论

儿童复发性KD的临床症状不典型。复发性KD与冠状动脉病变发生率增加有关。

相似文献

1
[Clinical features of recurrent Kawasaki disease in 20 children].20例复发性川崎病患儿的临床特征
Zhongguo Dang Dai Er Ke Za Zhi. 2008 Oct;10(5):617-9.
2
Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.川崎病患者早期静脉注射免疫球蛋白治疗。
J Pediatr. 2002 Apr;140(4):450-5. doi: 10.1067/mpd.2002.122469.
3
Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience.澳大利亚三级医疗机构中川崎病的诊断、治疗及预后:三年经验回顾
J Paediatr Child Health. 2005 Sep-Oct;41(9-10):495-9. doi: 10.1111/j.1440-1754.2005.00690.x.
4
Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.类固醇脉冲疗法对免疫球蛋白抵抗型川崎病的影响。
Arch Dis Child. 2008 Feb;93(2):142-6. doi: 10.1136/adc.2007.126144. Epub 2007 Oct 25.
5
[Risk factors for coronary artery lesions in children with Kawasaki disease].[川崎病患儿冠状动脉病变的危险因素]
Zhongguo Dang Dai Er Ke Za Zhi. 2012 Dec;14(12):938-41.
6
Characteristics of Kawasaki disease in older children.大龄儿童川崎病的特征
Clin Pediatr (Phila). 2011 Oct;50(10):952-6. doi: 10.1177/0009922811409027. Epub 2011 May 31.
7
Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.用中等剂量(1克/千克)静脉注射免疫球蛋白治疗川崎病。
J Med Assoc Thai. 2002 Nov;85 Suppl 4:S1121-6.
8
[Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].[三种静脉注射丙种球蛋白方案对小儿川崎病及相关冠状动脉并发症发生率的影响:一项对比研究]
Zhonghua Yi Xue Za Zhi. 2007 Nov 27;87(44):3119-21.
9
Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.伴有严重心脏后遗症的川崎病:新西兰近期经验教训
J Paediatr Child Health. 2004 Sep-Oct;40(9-10):524-9. doi: 10.1111/j.1440-1754.2004.00456.x.
10
Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.日本川崎病患者对初始静脉注射免疫球蛋白治疗无反应的潜在风险因素分析。
Pediatr Infect Dis J. 2008 Feb;27(2):155-60. doi: 10.1097/INF.0b013e31815922b5.

引用本文的文献

1
Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature.川崎病在 COVID-19 时代的复发:文献系统综述。
Ital J Pediatr. 2021 Apr 19;47(1):95. doi: 10.1186/s13052-021-01041-4.
2
[Clinical features of children with recurrent Kawasaki disease: a Meta analysis].[复发性川崎病患儿的临床特征:一项Meta分析]
Zhongguo Dang Dai Er Ke Za Zhi. 2020 Dec;22(12):1306-1312. doi: 10.7499/j.issn.1008-8830.2009138.
3
Kawasaki disease in children: Epidemiology, clinical symptoms and diagnostics of 231 cases in 10 years.
儿童川崎病:10年231例的流行病学、临床症状及诊断
Exp Ther Med. 2015 Jul;10(1):357-361. doi: 10.3892/etm.2015.2487. Epub 2015 May 11.
4
Recurrent Kawasaki disease: USA and Japan.复发性川崎病:美国和日本。
Pediatr Int. 2015 Dec;57(6):1116-20. doi: 10.1111/ped.12733. Epub 2015 Nov 5.